ATE406882T1 - Zusammensetzungen zur normalisierung des zirkadianen rythmus - Google Patents

Zusammensetzungen zur normalisierung des zirkadianen rythmus

Info

Publication number: ATE406882T1
Authority: AT; Austria
Prior art keywords: normalizing; action; circadian rhythm; composition; circadian
Prior art date: 2000-05-16

Application number

AT01930144T

Other languages

English (en)

Inventor

Yoshinobu Kiso

Yoshiko Ono

Katsuya Nagai

Original Assignee

Suntory Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-16

Filing date

2001-05-15

Publication date

2008-09-15

2001-05-15 Application filed by Suntory Ltd filed Critical Suntory Ltd

2008-09-15 Application granted granted Critical

2008-09-15 Publication of ATE406882T1 publication Critical patent/ATE406882T1/de

Links

239000000203 mixture Substances 0.000 title abstract 5
230000002060 circadian Effects 0.000 title 1
230000027288 circadian rhythm Effects 0.000 abstract 4
YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 abstract 2
DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 abstract 2
229960003987 melatonin Drugs 0.000 abstract 2
JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 abstract 1
229940022405 astaxanthin Drugs 0.000 abstract 1
235000013793 astaxanthin Nutrition 0.000 abstract 1
239000001168 astaxanthin Substances 0.000 abstract 1
235000013361 beverage Nutrition 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000002708 enhancing effect Effects 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
235000013305 food Nutrition 0.000 abstract 1
235000013376 functional food Nutrition 0.000 abstract 1
208000019116 sleep disease Diseases 0.000 abstract 1
208000020685 sleep-wake disease Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Non-Alcoholic Beverages (AREA)
Electrophonic Musical Instruments (AREA)

AT01930144T 2000-05-16 2001-05-15 Zusammensetzungen zur normalisierung des zirkadianen rythmus ATE406882T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2000143039		2000-05-16

Publications (1)

Publication Number	Publication Date
ATE406882T1 true ATE406882T1 (de)	2008-09-15

Family

ID=18649909

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01930144T ATE406882T1 (de)	2000-05-16	2001-05-15	Zusammensetzungen zur normalisierung des zirkadianen rythmus

Country Status (10)

Country	Link
US (1)	US7001611B2 (de)
EP (1)	EP1283038B1 (de)
AT (1)	ATE406882T1 (de)
AU (1)	AU780120B2 (de)
CA (1)	CA2374958C (de)
DE (1)	DE60135647D1 (de)
DK (1)	DK1283038T3 (de)
ES (1)	ES2312430T3 (de)
PT (1)	PT1283038E (de)
WO (1)	WO2001087291A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7357947B2 (en) *	2001-09-10	2008-04-15	Biomet, Inc.	Bone graft material incorporating demineralized bone matrix and lipids
US9782377B2 (en)	2003-03-27	2017-10-10	Suntory Holdings Limited	Composition for normalization of infradian rhythm
US20050071207A1 (en) *	2003-09-26	2005-03-31	E2Open Llc	Visibility and synchronization in a multi tier supply chain model
EP1711171A2 (de) *	2003-12-18	2006-10-18	DSMIP Assets B.V.	Vitamin e zur erleichterung der synchronisation des zirkadianen rhythmus
US20070128310A1 (en)	2003-12-19	2007-06-07	Meni-One Co., Ltd.	Astaxanthin-containing pet foods
US8086315B2 (en)	2004-02-12	2011-12-27	Asap Medical, Inc.	Cardiac stimulation apparatus and method for the control of hypertension
AR056076A1 (es) *	2005-09-20	2007-09-19	Takeda Pharmaceutical	Agente profilactico o terapeutico para el desorden de sueno
GB0523431D0 (en) *	2005-11-17	2005-12-28	Inst For Akvakulturforskning A	Method
US8192773B2 (en) *	2006-12-22	2012-06-05	Kemin Industries, Inc.	Carotenoid-based pigmenter
US20080171085A1 (en) *	2007-01-11	2008-07-17	Natrol, Inc.	Novel biphasic delivery system for a pharmaceutical or nutraceutical composition and method of administration
JP5356667B2 (ja) *	2007-09-28	2013-12-04	ユニチカ株式会社	体内時計正常化効果を有する組成物
MX2010010569A (es) *	2008-03-27	2010-11-04	Nestec Sa	Metodos para incrementar la absorcion de peptidos, peptidomimeticos y otros sustratos de proteina de transporte gastrointestinal.
EP2123166A1 (de) *	2008-05-15	2009-11-25	Unilever N.V.	Essbare Emulsionen mit Zitronensäureester
JP4409617B1 (ja) *	2008-12-04	2010-02-03	富士化学工業株式会社	カロテノイド色素の退色防止方法及びその容器体
RU2569743C2 (ru)	2009-09-11	2015-11-27	Нестек С.А.	Композиции и способы усиления когнитивной функции и связанных с ней функций у животных
US20130273176A1 (en) *	2010-12-07	2013-10-17	Nestec Sa	Methods and compositions useful for promoting sleep in animals
WO2014054651A1 (ja) *	2012-10-03	2014-04-10	富士フイルム株式会社	睡眠改善剤、ノンレム睡眠時間増加剤及び鎮静剤
US9008769B2 (en)	2012-12-21	2015-04-14	Backbeat Medical, Inc.	Methods and systems for lowering blood pressure through reduction of ventricle filling
US9370662B2 (en)	2013-12-19	2016-06-21	Backbeat Medical, Inc.	Methods and systems for controlling blood pressure by controlling atrial pressure
US10342982B2 (en)	2015-09-11	2019-07-09	Backbeat Medical, Inc.	Methods and systems for treating cardiac malfunction
CN105193794B (zh) *	2015-11-12	2018-03-27	邵小春	一种睡眠喷剂及其制备方法
US10485658B2 (en)	2016-04-22	2019-11-26	Backbeat Medical, Inc.	Methods and systems for controlling blood pressure
US10426400B2 (en)	2017-06-23	2019-10-01	International Business Machines Corporation	Optimized individual sleep patterns
JP2022188309A (ja) *	2019-11-18	2022-12-21	Ｅｎｅｏｓ株式会社	睡眠の質の改善のための組成物
CN110882245A (zh) *	2019-12-16	2020-03-17	厦门市健康医疗大数据中心(厦门市医药研究所)	一种改善睡眠的组合物及其用途
RU2735833C1 (ru) *	2020-03-25	2020-11-09	Федеральное государственное бюджетное учреждение "Северо-Кавказский федеральный научно-клинический центр Федерального медико-биологического агентства"	Способ коррекции десинхроноза суточных биоритмов человека, вызванного повышенными физическими и психоэмоциональными нагрузками
CN113144093B (zh) *	2021-05-23	2022-07-01	中国人民解放军海军第九七一医院	一种治疗昼夜节律紊乱的中药组合物与应用及其丸剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2619491B2 (ja)	1988-08-11	1997-06-11	サントリー株式会社	アスタキサンチン含有組成物
JPH05124958A (ja) *	1991-09-19	1993-05-21	Yukio Date	過酸化脂質低下作用を有する組成物
JPH07300421A (ja)	1994-04-28	1995-11-14	Itano Reitou Kk	抗炎症剤
JPH09124470A (ja)	1995-10-26	1997-05-13	Suntory Ltd	抗ストレス組成物
JPH10155459A (ja) *	1996-11-27	1998-06-16	Suntory Ltd	アスタキサンチン含有飲食物

2001
- 2001-05-15 EP EP01930144A patent/EP1283038B1/de not_active Expired - Lifetime
- 2001-05-15 PT PT01930144T patent/PT1283038E/pt unknown
- 2001-05-15 ES ES01930144T patent/ES2312430T3/es not_active Expired - Lifetime
- 2001-05-15 WO PCT/JP2001/004027 patent/WO2001087291A1/ja not_active Ceased
- 2001-05-15 AU AU56740/01A patent/AU780120B2/en not_active Ceased
- 2001-05-15 DK DK01930144T patent/DK1283038T3/da active
- 2001-05-15 AT AT01930144T patent/ATE406882T1/de not_active IP Right Cessation
- 2001-05-15 DE DE60135647T patent/DE60135647D1/de not_active Expired - Lifetime
- 2001-05-15 CA CA2374958A patent/CA2374958C/en not_active Expired - Lifetime
- 2001-05-15 US US10/030,715 patent/US7001611B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DK1283038T3 (da)	2008-12-01
WO2001087291A1 (fr)	2001-11-22
EP1283038A1 (de)	2003-02-12
US7001611B2 (en)	2006-02-21
US20030091614A1 (en)	2003-05-15
EP1283038A4 (de)	2003-06-25
CA2374958A1 (en)	2001-11-22
ES2312430T3 (es)	2009-03-01
AU5674001A (en)	2001-11-26
CA2374958C (en)	2010-06-01
DE60135647D1 (de)	2008-10-16
HK1053269A1 (en)	2003-10-17
AU780120B2 (en)	2005-03-03
PT1283038E (pt)	2008-10-23
EP1283038B1 (de)	2008-09-03

Similar Documents

Publication	Publication Date	Title
ATE406882T1 (de)	2008-09-15	Zusammensetzungen zur normalisierung des zirkadianen rythmus
TW200608979A (en)	2006-03-16	Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
IL183401A (en)	2013-09-30	Use of ornithine and ornithine with at least one of phenylacetate and phenylbutyrate in the manufacture of products and compositions containing them for use in preventing or treating liver decompensation or hepatic encephalopathy
DE60236541D1 (de)	2010-07-08	Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
MY147643A (en)	2012-12-31	Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
MXPA04004837A (es)	2004-08-02	Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
DE60043318D1 (de)	2010-01-14	Synergistische kombination von pumafentrine und salmeterol
EA201070121A1 (ru)	2010-06-30	Лекарственная форма, содержащая слитый белок glp-1-fc
BR0316350A (pt)	2005-09-27	Diaminotriazóis úteis como inibidores de proteìna cinases
CY1108794T1 (el)	2014-04-09	Σπειροκυκλικα παραγωγα κυκλοεξανιου
ATE113837T1 (de)	1994-11-15	Mittel zur bekämpfung des schmerzes, der depression und zur beruhigung.
ATE538666T1 (de)	2012-01-15	Nahrungsergänzung zur verhinderung von abmagerungen
EP1767212A4 (de)	2009-12-16	Verwendung der pflanze der gattung ampelopsis und deren extrakte zur herstellung von arzneimitteln und functional food
ATE537828T1 (de)	2012-01-15	Psychotropes mittel und nahrungsmittel zur förderung der gesundheit enthaltend neferin
MXPA05013226A (es)	2006-03-09	Carbamatos de piperidina sustituidos, para el uso como inhibidores de la lipasa sensible a hormonas.
WO2005062992A3 (en)	2005-08-18	Substituted melatonin derivatives, process for their preparation, and methods of use
WO2004110373A3 (en)	2005-04-14	Therapeutic vaccine compositions for the treatment of type 1 diabetes
DE60101859D1 (de)	2004-03-04	Pinolensäure gegen Diabetes
EP1161948A3 (de)	2003-01-08	Pharmazeutische zusammensetzung und Nahrungsmittel zur Behandlung von Gehirnödem
SE0203817D0 (sv)	2002-12-20	New composition
IL182297A0 (en)	2008-04-13	The use of winter savory (satureja montana) or the extracts thereof for the preparation of medicaments for the treatment of the premature ejaculation
ATE293983T1 (de)	2005-05-15	Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie
ATE363273T1 (de)	2007-06-15	Verwendung von itakonsäure zur regulierung des glykolytischen stoffwechsels
ATE427108T1 (de)	2009-04-15	Anticholinergika enthaltende arzneimittel zur behandlung von krankheiten der ableitenden harnwege
DE60335810D1 (de)	2011-03-03	Medizinische zusammensetzungen zur hemmung der expression von atp-citrat-lyase und ihre verwendung

Legal Events

Date	Code	Title	Description
2009-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties